journal article·2023-02-28Open access

Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles

Shulan Han, Yongjie Chi, Zhu Yang, Juan Ma, Lianyan Wang

Abstract

Although we have made remarkable achievements in cancer awareness and medical technology, there are still tremendous increases in cancer incidence and mortality. However, most anti-tumor strategies, including immunotherapy, show low efficiency in clinical application. More and more evidence suggest that this low efficacy may be closely related to the immunosuppression of the tumor microenvironment (TME). The TME plays a significant role in tumorigenesis, development, and metastasis. Therefore, it is necessary to regulate the TME during antitumor therapy. Several strategies are developing to regulate the TME as inhibiting tumor angiogenesis, reversing tumor associated macrophage (TAM) phenotype, removing T cell immunosuppression, and so on. Among them, nanotechnology shows great potential for delivering regulators into TME, which further enhance the antitumor therapy efficacy. Properly designed nanomaterials can carry regulators and/or therapeutic agents to eligible locations or cells to trigger specific immune response and further kill tumor cells. Specifically, the designed nanoparticles could not only directly reverse the primary TME immunosuppression, but also induce effective systemic immune response, which would prevent niche formation before metastasis and inhibit tumor recurrence. In this review, we summarized the development of nanoparticles (NPs) for anti-cancer therapy, TME regulation, and tumor metastasis inhibition. We also discussed the prospect and potential of nanocarriers for cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China

Key Laboratory of Green Process and Engineering, State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China

University of Chinese Academy of Sciences, Beijing 100049, China

Department of Clinical Laboratory Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China

Funding

National Natural Science Foundation of China · Beijing Natural Science Foundation

References (100+)

Show source-provided references
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries10.3322/caac.21660 ↗
2. Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in Cancer10.1021/acsnano.6b00320 ↗
3. Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy10.1016/j.jconrel.2017.04.011 ↗
4. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma10.1016/j.ultrasmedbio.2012.04.015 ↗
5. Excisional surgery for cancer cure: Therapy at a cost10.1016/S1470-2045(03)01282-8 ↗
6. Chimeric Antigen Receptor T Cell Based Immunotherapy for Cancer10.2174/1574888X13666180420110239 ↗
7. A review of cancer immunotherapy toxicity10.3322/caac.21596 ↗
8. Immuno-Oncology: Emerging Targets and Combination Therapies10.3389/fonc.2018.00315 ↗
9. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy10.1038/s41467-021-20893-2 ↗
10. Tackling TAMs for Cancer Immunotherapy: It’s Nano Time10.1016/j.tips.2020.08.003 ↗
11. Cell Death Mediated by the Pyroptosis Pathway with the Aid of Nanotechnology: Prospects for Cancer Therapy10.1002/anie.202010281 ↗
12. Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy10.1208/s12248-019-0333-y ↗
13. Innate and adaptive immune cells in the tumor microenvironment10.1038/ni.2703 ↗
14. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes10.7150/thno.50928 ↗
15. Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis10.1136/jitc-2020-001367 ↗
16. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death10.2147/IJN.S314506 ↗
17. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response10.1021/nn5066793 ↗
18. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia10.1016/j.actbio.2021.08.015 ↗
19. Enhanced treatment effect of nanoparticles containing cisplatin and a GSH-reactive probe compound10.1016/j.msec.2018.11.039 ↗
20. Transdermal delivery system based on heparin-modified graphene oxide for deep transportation, tumor microenvironment regulation, and immune activation10.1016/j.nantod.2022.101565 ↗
21. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy10.1016/j.actbio.2017.11.010 ↗
22. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway10.1021/acsnano.8b05189 ↗
23. TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy10.1016/j.actbio.2022.03.001 ↗
24. Magnetically sensitive nanocomplex enhances antitumor efficacy of dendritic cell-based immunotherapy10.32471/exp-oncology.2312-8852.vol-43-no-3.16507 ↗
25. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages10.1039/C9NR03353J ↗
26. Mulla, M.Z., Rahman, M.R.T., Marcos, B., Tiwari, B., and Pathania, S. (2021). Poly Lactic Acid (PLA) Nanocomposites: Effect of Inorganic Nanoparticles Reinforcement on Its Performance and Food Packaging Applications. Molecules, 26.10.3390/molecules26071967 ↗
27. KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity10.1172/JCI31350 ↗
28. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients10.1158/1078-0432.CCR-08-2982 ↗
29. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy10.1038/nature18300 ↗
30. Immunotherapy: Cancer vaccine triggers antiviral-type defences10.1038/nature18443 ↗
31. Bacterial outer membrane vesicles as a candidate tumor vaccine platform10.3389/fimmu.2022.987419 ↗
32. Research advance in lipid nanoparticle-mRNA delivery system and its application in CAR-T cell therapy
33. A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses10.1038/s41467-022-33301-0 ↗
34. Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody10.1021/acs.nanolett.5b05030 ↗
35. Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma10.1016/j.jconrel.2019.05.036 ↗
36. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis10.1016/j.jconrel.2013.08.021 ↗
37. Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma10.1016/j.biomaterials.2015.07.053 ↗
38. Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment10.1016/j.jconrel.2016.11.013 ↗
39. Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy10.1016/j.biomaterials.2016.04.010 ↗
40. Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy10.1016/j.biomaterials.2014.09.007 ↗
41. A Core-Shell Nanoplatform for Synergistic Enhanced Sonodynamic Therapy of Hypoxic Tumor via Cascaded Strategy10.1002/adhm.201800819 ↗
42. The application of nitric oxide delivery in nanoparticle-based tumor targeting drug delivery and treatment10.1016/j.ajps.2018.10.005 ↗
43. One-Step Fabrication of Multifunctional PLGA-HMME-DTX@MnO(2) Nanoparticles for Enhanced Chemo-Sonodynamic Antitumor Treatment10.2147/IJN.S365570 ↗
44. In situ forming oxygen/ROS-responsive niche-like hydrogel enabling gelation-triggered chemotherapy and inhibition of metastasis10.1016/j.bioactmat.2022.08.002 ↗
45. Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics10.7150/thno.29569 ↗
46. Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy10.1016/j.ajps.2019.04.005 ↗
47. Multifunctional MnO(2) nanoparticles for tumor microenvironment modulation and cancer therapy10.1002/wnan.1720 ↗
48. Gold nanocage-photosensitizer conjugates for dual-modal image-guided enhanced photodynamic therapy10.7150/thno.7064 ↗
49. Synergistic Integration of Layer-by-Layer Assembly of Photosensitizer and Gold Nanorings for Enhanced Photodynamic Therapy in the Near Infrared10.1021/acsnano.5b03063 ↗
50. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma10.1126/scitranslmed.abb3945 ↗
51. Haque, S., Norbert, C.C., Acharyya, R., Mukherjee, S., Kathirvel, M., and Patra, C.R. (2021). Biosynthesized Silver Nanoparticles for Cancer Therapy and In Vivo Bioimaging. Cancers, 13.10.3390/cancers13236114 ↗
52. Effects of green-synthesized silver nanoparticles on lung cancer cells in vitro and grown as xenograft tumors in vivo10.2147/IJN.S103695 ↗
53. Targeted delivery of 5-aminolevulinic acid by multifunctional hollow mesoporous silica nanoparticles for photodynamic skin cancer therapy10.1021/acsami.5b03087 ↗
54. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape10.1016/j.biomaterials.2012.07.025 ↗
55. Phase I trial of liposomal encapsulated doxorubicin (Myocet; D-99) and weekly docetaxel in advanced breast cancer patients10.1093/annonc/mdi209 ↗
56. A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer10.1038/sj.bjc.6600250 ↗
57. Liposomal doxorubicin (Doxil): An effective new treatment for Kaposi’s sarcoma in AIDS10.1016/S0936-6555(05)80269-9 ↗
58. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice10.1053/j.gastro.2017.10.050 ↗
59. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: First member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee
60. New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy10.1002/adfm.200801655 ↗
61. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies10.1158/1078-0432.CCR-03-0655 ↗
62. Liposomal, nanoparticle, and conjugated formulations of anticancer agents10.1158/1078-0432.CCR-05-1895 ↗
63. Preparation, therapeutic efficacy and intratumoral localization of targeted daunorubicin liposomes conjugating folate-PEG-CHEMS10.1016/j.biopha.2010.10.003 ↗
64. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver10.1016/j.jconrel.2012.12.017 ↗
65. pH and redox dual-responsive biodegradable polymeric micelles with high drug loading for effective anticancer drug delivery10.1016/j.nano.2016.09.016 ↗
66. Modulated protonation of side chain aminoethylene repeats in N-substituted polyaspartamides promotes mRNA transfection10.1021/ja506194z ↗
67. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date10.1007/s11095-016-1958-5 ↗
68. A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors10.1007/s00280-008-0813-8 ↗
69. Investigational nanomedicines in 2016: A review of nanotherapeutics currently undergoing clinical trials10.1002/wnan.1416 ↗
70. Progress in Nanomedicine: Approved and Investigational Nanodrugs
71. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line10.1186/1477-3155-10-46 ↗
72. Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy10.1002/smll.202006484 ↗
73. Dendritic Cell-Based Immunotherapy: State of the Art and Beyond10.1158/1078-0432.CCR-15-1399 ↗
74. Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma10.1016/j.apsb.2018.12.009 ↗
75. Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy10.1002/adhm.201500998 ↗
76. Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications10.1016/j.ymeth.2019.12.004 ↗
77. Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications
78. Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors10.1038/s41467-021-22311-z ↗
79. In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy10.1038/s41551-016-0011 ↗
80. Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets10.1038/s41551-021-00712-1 ↗
81. Near-infrared light-triggered platelet arsenal for combined photothermal-immunotherapy against cancer10.1126/sciadv.abd7614 ↗
82. Bioengineered Platelets Combining Chemotherapy and Immunotherapy for Postsurgical Melanoma Treatment: Internal Core-Loaded Doxorubicin and External Surface-Anchored Anti-PD-L1 Antibody Backpacks10.1021/acs.nanolett.2c00907 ↗
83. Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer10.1016/j.jconrel.2015.01.039 ↗
84. Monocyte-mediated chemotherapy drug delivery in glioblastoma10.2217/nnm-2017-0266 ↗
85. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles10.1038/ncomms2282 ↗
86. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis10.1016/j.ccr.2006.01.025 ↗
87. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells10.1016/j.jconrel.2015.09.031 ↗
88. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells10.1038/mt.2012.180 ↗
89. TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site10.1158/1078-0432.CCR-15-2170 ↗
90. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance10.1073/pnas.2232479100 ↗
91. Plasmonic photothermal therapy (PPTT) using gold nanoparticles10.1007/s10103-007-0470-x ↗
92. Application of nanodimensional particles and aluminum hydroxide nanostructures for cancer diagnosis and therapy10.1063/1.5001615 ↗
93. Gold nanoparticles in biology and medicine: Recent advances and prospects10.32607/20758251-2011-3-2-34-55 ↗
94. Applications of Gold and Silver Nanoparticles in Theranostics10.1007/s12010-022-03963-z ↗
95. Colloidal plasmonic gold nanoparticles and gold nanorings: Shape-dependent generation of singlet oxygen and their performance in enhanced photodynamic cancer therapy10.2147/IJN.S156347 ↗
96. ICG-Loaded PEGylated BSA-Silver Nanoparticles for Effective Photothermal Cancer Therapy10.2147/IJN.S255874 ↗
97. Phyto-synthesized Gold Nanoparticles as Antitumor Agents10.2174/2211738508999201123213504 ↗
98. Plant-mediated green synthesis of metal-based nanoparticles for dermopharmaceutical and cosmetic applications10.1016/j.ijpharm.2021.120311 ↗
99. Anticancer, antimicrobial, antioxidant, and catalytic activities of green-synthesized silver and gold nanoparticles using Bauhinia purpurea leaf extract10.1007/s00449-018-2035-8 ↗
100. Preliminary investigation of catalytic, antioxidant, anticancer and bactericidal activity of green synthesized silver and gold nanoparticles using Actinidia deliciosa10.1016/j.jphotobiol.2017.03.023 ↗